Literature DB >> 21382583

The enteric microbiota in the pathogenesis and management of constipation.

E M M Quigley1.   

Abstract

For centuries, fiber has been recommended on an empirical basis for the management of constipation; it has only been in recent decades that the mechanisms whereby fiber and related products may influence colonic function have begun to be elucidated. The interaction between fiber and the microbiota of the human colon appears to play a major role in generating the beneficial effects of fiber. The microbiota is also the target for the other therapeutic interventions discussed in this chapter: prebiotics and probiotics. While a scientific basis for a role for these approaches in the management of constipation continues to develop, evidence from high-quality clinical trials to support their use in daily practice continues to lag far behind. While benefits for fiber and, perhaps, for certain prebiotic and probiotic preparations in constipation appear to be extant there is a real need for large well-conducted clinical trials in this important area of human medicine.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21382583     DOI: 10.1016/j.bpg.2011.01.003

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  32 in total

Review 1.  A review of the pharmacobiotic regulation of gastrointestinal inflammation by probiotics, commensal bacteria and prebiotics.

Authors:  L Vitetta; D Briskey; E Hayes; C Shing; J Peake
Journal:  Inflammopharmacology       Date:  2012-03-18       Impact factor: 4.473

Review 2.  American Gastroenterological Association technical review on constipation.

Authors:  Adil E Bharucha; John H Pemberton; G Richard Locke
Journal:  Gastroenterology       Date:  2013-01       Impact factor: 22.682

Review 3.  Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis.

Authors:  Min-Min Zhang; Wei Qian; Ying-Yi Qin; Jia He; Yu-Hao Zhou
Journal:  World J Gastroenterol       Date:  2015-04-14       Impact factor: 5.742

4.  Constipation and risk of death and cardiovascular events.

Authors:  Keiichi Sumida; Miklos Z Molnar; Praveen K Potukuchi; Fridtjof Thomas; Jun Ling Lu; Kunihiro Yamagata; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Atherosclerosis       Date:  2018-12-23       Impact factor: 5.162

5.  Constipation and Incident CKD.

Authors:  Keiichi Sumida; Miklos Z Molnar; Praveen K Potukuchi; Fridtjof Thomas; Jun Ling Lu; Kunihiro Matsushita; Kunihiro Yamagata; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  J Am Soc Nephrol       Date:  2016-11-10       Impact factor: 10.121

6.  Real-time PCR analysis of the intestinal microbiotas in peritoneal dialysis patients.

Authors:  I-Kuan Wang; Hsueh-Chou Lai; Cheng-Ju Yu; Chih-Chia Liang; Chiz-Tzung Chang; Huey-Liang Kuo; Ya-Fei Yang; Chung-Chih Lin; Hsin-Hung Lin; Yao-Lung Liu; Yi-Chih Chang; Yi-Ying Wu; Chu-Huang Chen; Chi-Yuan Li; Feng-Rong Chuang; Chiu-Ching Huang; Chih-Hsueh Lin; Hung-Chih Lin
Journal:  Appl Environ Microbiol       Date:  2011-12-16       Impact factor: 4.792

7.  Laxative use in patients with advanced chronic kidney disease transitioning to dialysis.

Authors:  Keiichi Sumida; Ankur A Dashputre; Praveen K Potukuchi; Fridtjof Thomas; Yoshitsugu Obi; Miklos Z Molnar; Justin D Gatwood; Elani Streja; Kamyar Kalantar-Zadeh; Csaba P Kovesdy
Journal:  Nephrol Dial Transplant       Date:  2021-11-09       Impact factor: 5.992

Review 8.  Chronic Constipation.

Authors:  Adil E Bharucha; Arnold Wald
Journal:  Mayo Clin Proc       Date:  2019-05-01       Impact factor: 7.616

Review 9.  Holistic Approach to Functional Constipation: Perspective of Traditional Persian Medicine.

Authors:  Majid Nimrouzi; Mohammad M Zarshenas
Journal:  Chin J Integr Med       Date:  2015-11-23       Impact factor: 1.978

Review 10.  Contributions of the microbial hydrogen economy to colonic homeostasis.

Authors:  Franck Carbonero; Ann C Benefiel; H Rex Gaskins
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-15       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.